Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-08-12 Purchase | 2024-08-13 10:55 am | Lexaria Bioscience Corp. | LEXX | TURKEL CATHERINE C. Director | 1,600 | $3.13 | $5,008 | 65,000 (Direct) | View |
| 2023-02-09 Purchase | 2023-02-27 10:52 am | Lexaria Bioscience Corp. | LEXX | TURKEL CATHERINE C. Director | 1,500 | $2.8446 | $4,267 | 9,900 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-07-26 Option Award | 2024-07-30 11:32 am | 2024-07-26 2029-07-26 | Lexaria Bioscience Corp. | LEXX | TURKEL CATHERINE C. Director | 12,000 | $0 | 61,900 (Direct) | View |
| 2024-04-26 Option Award | 2024-05-10 5:16 pm | 2024-04-26 2029-04-26 | Lexaria Bioscience Corp. | LEXX | TURKEL CATHERINE C. Director | 5,000 | $0 | 34,900 (Direct) | View |
| 2023-07-25 Option Award | 2023-07-25 1:44 pm | 2023-07-25 2028-07-25 | Lexaria Bioscience Corp. | LEXX | TURKEL CATHERINE C. Director | 5,000 | $0 | 19,900 (Direct) | View |
| 2022-10-12 Option Award | 2022-10-13 5:16 pm | 2022-10-12 2027-10-12 | Lexaria Bioscience Corp. | LEXX | TURKEL CATHERINE C. Director | 1,600 | $0 | 8,400 (Direct) | View |
| 2022-09-02 Option Award | 2022-09-06 12:53 pm | 2022-09-02 2027-09-02 | Lexaria Bioscience Corp. | LEXX | TURKEL CATHERINE C. Director | 3,400 | $0 | 3,400 (Direct) | View |
| 2020-03-19 Option Award | 2020-03-20 4:31 pm | N/A 2030-03-19 | Novus Therapeutics Inc. | NVUS | TURKEL CATHERINE C. President | 100,000 | $0 | 100,000 (Direct) | View |